Cambridge Healthtech Institute’s 11th Annual

Advances in Immunotherapy

Supercharging the Immune System

May 12-13, 2026

 

Cambridge Healthtech Institute’s 11th annual Advances in Immunotherapy conference explores the most recent breakthroughs shaping the future of immunotherapy for oncology and autoimmune disease. Key topics include: overcoming resistance, targeting the TME, harnessing the microbiome to improve outcomes, dual-targeting CAR Ts, engineering safer and more effective cell therapies, and advancing rational combination approaches. Examples will come from the worlds of biotherapeutics, proteins, cell-based therapies, and more.

 

Coverage will include, but is not limited to:

 

Overcoming Resistance and Limitations in Immunotherapy

  • Latest advances in overcoming tumor microenvironment
  • Overcoming resistance and evasion
  • Next-generation checkpoints—targeting combination checkpoint pathways
  • Advances in immunocytokines
  • Impact of microbiome on immunotherapies

Engineering Safer, More Efficacious Cell Therapies

  • Dual Targeting Cell Therapies
  • Armored CAR Ts—reshape the tumor microenvironment and sustain T cell function
  • Novel CAR designs, gene-edited/base-edited CARs
  • Synthetic immune receptors
  • Engineer CAR Ts that mimic native TCR synapse formation
  • CAR T switches, logic gates to control function and safety
  • Mitigating toxicity and resistance

Cell Therapies against Solid Tumors

  • Latest engineering strategies to target solid tumors
  • CAR T against solid tumors
  • TCR Ts to target solid tumors
  • Advances in CAR-NKs, RNA Cell Therapies, T Regs, Gamma deltas
  • Genetically modified cell therapies
  • Next-generation TILs—updates

Cell Therapies and Immunotherapies for Autoimmune and Fibrosis

  • Latest immunotherapy and cell therapy strategies to target autoimmune disease
  • CAR T for autoimmune—updates from major players: Cartesian, Cabaletta Bio
  • Agonists against autoimmune disease
  • Next-generation autoimmune therapies

 

The deadline for priority consideration is October 17, 2025.

 

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

 

Opportunities for Participation:

 


For more details on the conference, please contact:

Daniel Barry

Senior Conference Director

Cambridge Healthtech Institute

Phone: : (+44) 7837-651-303

Email: dbarry@healthtech.com

 

For sponsorship information, please contact:

Companies A-K

Jason Gerardi

Sr. Manager, Business Development

Cambridge Healthtech Institute

Phone: 781-972-5452

Email: jgerardi@healthtech.com

 

Companies L-Z

Ashley Parsons

Manager, Business Development

Cambridge Healthtech Institute

Phone: 781-972-1340

Email: ashleyparsons@healthtech.com


Register

View By:


Premier Sponsors

FairJourneyBiologics GenScript-CRO Integral-Molecular_NEW   Nona_Biosciences_NEW